135 DAFTAR PUSTAKA Achanta, P. S., Chen, S. N., dan Pauli, G. F. (2021): Plain 1 H nuclear magnetic resonance analysis streamlines the quality control of antiviral favipiravir and congeneric World Health Organization essential medicines, Magnetic Resonance in Chemistry, 59(7), 746–751. Achelle, S., Baudequin, C., dan Plé, N. (2013): Luminescent materials incorporating pyrazine or quinoxaline moieties, Dyes and Pigments, 98(3), 575–600. Adams, J., dan Kauffman, M. (2004): Development of the proteasome inhibitor Velcade TM (Bortezomib), Cancer Investigation, 22(2), 304–311. Agarwal, R., Singh, A., dan Sen, S. (2016): Role of Molecular Docking in Computer-Aided Drug Design and Development, 1–28 in Applied Case Studies and Solutions in Molecular Docking-Based Drug Design. Agrawal, U., Raju, R., dan Udwadia, Z. F. (2020): Favipiravir: A new and emerging antiviral option in COVID-19, Medical Journal Armed Forces India, 76(4), 370–376. Annenkov, A. (2014): Receptor tyrosine kinase (RTK) signalling in the control of neural stem and progenitor cell (NSPC) development, Molecular Neurobiology, 49(1), 440–471. Arora, A., dan Scholar, E. M. (2005): Role of tyrosine kinase inhibitors in cancer therapy, Journal of Pharmacology and Experimental Therapeutics, 315(3), 971–979. Avraham, H., Park, S., Schinkmann, K., dan Avraham, S. (2000): RAFTK / Pyk2- mediated cellular signalling, Cellular Signalling, 12, 123–133. Azevedo, A., Silva, S., dan Rueff, J. (2019): Non-receptor Tyrosine Kinases Role and Significance in Hematological Malignancies dalam H. Ren, ed., Tyrosine Kinases as Druggable Targets in Cancer , IntechOpen., Tyrosine Kinases as Druggable Targets in Cancer, 2019. Baker, R., dan Rao, V. B. (1982): Synthesis of optically pure (R,Z )-5-dec-1- enyloxacyclopentan-2- one, the sex pheromone of the Japanese beetle, Journal of The Chemical Society, 1, 69–71. Belanger, D. B., Curran, P. J., Hruza, A., Voigt, J., Meng, Z., Mandal, A. K., Siddiqui, M. A., Basso, A. D., dan Gray, K. (2010): Discovery of imidazo[1,2-a]pyrazine-based Aurora kinase inhibitors, Bioorganic and Medicinal Chemistry Letters, 20(17), 5170–5174. Beldar, S. V., dan Jordis, U. (2009): Synthetic studies towards the antiviral pyrazine derivative T-705, Vienna University of Technology, 13. Bentley, P. J. (1968): Amiloride: a potent inhibitor of sodium transport across the toad bladder, The Journal of Physiology, 195(2), 317–330. Bhullar, K. S., Lagaron, N. O., McGowan, E. M., Parman, I., Jha, A., Hubbard, B. P., dan Rupasinghe, H. P. V. (2018): Kinase-targeted cancer therapies: progress, challenges and future directions, Molecular Cancer, 17(48). Blair, H. A., dan Plosker, G.